ELIOR GROUP (ELIOR.PA)

FR0011950732 - Common Stock

2.462  -0.02 (-0.97%)

Fundamental Rating

2

Taking everything into account, ELIOR scores 2 out of 10 in our fundamental rating. ELIOR was compared to 49 industry peers in the Hotels, Restaurants & Leisure industry. ELIOR may be in some trouble as it scores bad on both profitability and health. ELIOR has a correct valuation and a medium growth rate.



1

1. Profitability

1.1 Basic Checks

ELIOR had negative earnings in the past year.
In the past year ELIOR had a positive cash flow from operations.
In the past 5 years ELIOR reported 4 times negative net income.
In multiple years ELIOR reported negative operating cash flow during the last 5 years.

1.2 Ratios

ELIOR has a worse Return On Assets (-2.43%) than 71.74% of its industry peers.
ELIOR's Return On Equity of -10.98% is on the low side compared to the rest of the industry. ELIOR is outperformed by 63.04% of its industry peers.
ELIOR has a worse Return On Invested Capital (0.86%) than 71.74% of its industry peers.
Industry RankSector Rank
ROA -2.43%
ROE -10.98%
ROIC 0.86%
ROA(3y)-6.07%
ROA(5y)-4.91%
ROE(3y)-25.24%
ROE(5y)-20.33%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

ELIOR's Operating Margin of 0.50% is on the low side compared to the rest of the industry. ELIOR is outperformed by 71.74% of its industry peers.
In the last couple of years the Operating Margin of ELIOR has declined.
The Gross Margin of ELIOR (68.29%) is better than 63.04% of its industry peers.
In the last couple of years the Gross Margin of ELIOR has remained more or less at the same level.
Industry RankSector Rank
OM 0.5%
PM (TTM) N/A
GM 68.29%
OM growth 3YN/A
OM growth 5Y-24.87%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.36%
GM growth 5Y0.05%

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ELIOR is destroying value.
The number of shares outstanding for ELIOR has been increased compared to 1 year ago.
Compared to 5 years ago, ELIOR has more shares outstanding
Compared to 1 year ago, ELIOR has an improved debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of 1.34, we must say that ELIOR is in the distress zone and has some risk of bankruptcy.
ELIOR has a Altman-Z score (1.34) which is in line with its industry peers.
ELIOR has a Debt/Equity ratio of 1.51. This is a high value indicating a heavy dependency on external financing.
ELIOR has a Debt to Equity ratio of 1.51. This is comparable to the rest of the industry: ELIOR outperforms 41.30% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.51
Debt/FCF N/A
Altman-Z 1.34
ROIC/WACC0.14
WACC6.08%

2.3 Liquidity

A Current Ratio of 0.73 indicates that ELIOR may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.73, ELIOR is doing worse than 69.57% of the companies in the same industry.
A Quick Ratio of 0.67 indicates that ELIOR may have some problems paying its short term obligations.
ELIOR's Quick ratio of 0.67 is on the low side compared to the rest of the industry. ELIOR is outperformed by 76.09% of its industry peers.
Industry RankSector Rank
Current Ratio 0.73
Quick Ratio 0.67

4

3. Growth

3.1 Past

ELIOR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 83.06%, which is quite impressive.
The Revenue has grown by 17.34% in the past year. This is quite good.
The Revenue has been growing slightly by 1.34% on average over the past years.
EPS 1Y (TTM)83.06%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q66.67%
Revenue 1Y (TTM)17.34%
Revenue growth 3Y9.6%
Revenue growth 5Y1.34%
Revenue growth Q2Q24.1%

3.2 Future

The Earnings Per Share is expected to grow by 41.31% on average over the next years. This is a very strong growth
Based on estimates for the next years, ELIOR will show a small growth in Revenue. The Revenue will grow by 5.58% on average per year.
EPS Next Y189.38%
EPS Next 2Y88.57%
EPS Next 3Y58.42%
EPS Next 5Y41.31%
Revenue Next Year15.57%
Revenue Next 2Y9.55%
Revenue Next 3Y7.68%
Revenue Next 5Y5.58%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

4

4. Valuation

4.1 Price/Earnings Ratio

ELIOR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 12.63, ELIOR is valued correctly.
Based on the Price/Forward Earnings ratio, ELIOR is valued cheaper than 80.43% of the companies in the same industry.
ELIOR's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.74.
Industry RankSector Rank
PE N/A
Fwd PE 12.63

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as ELIOR.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.04

4.3 Compensation for Growth

ELIOR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ELIOR's earnings are expected to grow with 58.42% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y88.57%
EPS Next 3Y58.42%

0

5. Dividend

5.1 Amount

No dividends for ELIOR!.
Industry RankSector Rank
Dividend Yield N/A

ELIOR GROUP

EPA:ELIOR (3/28/2024, 2:49:44 PM)

2.462

-0.02 (-0.97%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap622.16M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 12.63
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.43%
ROE -10.98%
ROCE
ROIC
ROICexc
ROICexgc
OM 0.5%
PM (TTM) N/A
GM 68.29%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.36
Health
Industry RankSector Rank
Debt/Equity 1.51
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.73
Quick Ratio 0.67
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)83.06%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y189.38%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)17.34%
Revenue growth 3Y9.6%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y